Focus Partners Wealth’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.06M Sell
197,303
-3,839
-2% -$86.5K ﹤0.01% 1011
2025
Q4
$4.77M Sell
201,142
-2,146
-1% -$52.2K 0.01% 962
2025
Q3
$5.06M Buy
203,288
+105,827
+109% +$2.28M 0.01% 742
2025
Q2
$2.24M Buy
+97,461
New +$2.26M ﹤0.01% 872
2024
Q2
Sell
-74,808
Closed -$1.47M 1259
2024
Q1
$1.47M Buy
74,808
+40,325
+117% +$852K 0.01% 533
2023
Q4
$794K Buy
+34,483
New +$772K 0.01% 490

Other funds holding PRVA

Focus Partners Wealth's PRVA Position: Q1 2026 in Review

Focus Partners Wealth reduced its Privia Health (PRVA) stake by 1.9% in Q1 2026, selling an estimated $86.5K and leaving 197,303 shares worth $4.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Focus Partners Wealth first reported a position in PRVA in Q4 2023 and has held it in 6 quarters since. The position peaked at $5.06M in Q3 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Focus Partners Wealth held 197,303 shares of Privia Health worth $4.06M as of Q1 2026.
  • Focus Partners Wealth sold 3,839 Privia Health shares in Q1 2026, an estimated $86.5K.
  • Privia Health made up ﹤0.01% of Focus Partners Wealth's portfolio in Q1 2026, its #1011 holding.
  • Focus Partners Wealth first reported a position in Privia Health in Q4 2023 and has held it in 6 quarters since.
  • Focus Partners Wealth's Privia Health position peaked at $5.06M in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Focus Partners Wealth's 13F filing for Q1 2026, filed 15 May 2026.